Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - ACHIEVE LIFE SCIENCES, INC. | achv-ex322_7.htm |
| EX-32.1 - EX-32.1 - ACHIEVE LIFE SCIENCES, INC. | achv-ex321_10.htm |
| EX-31.2 - EX-31.2 - ACHIEVE LIFE SCIENCES, INC. | achv-ex312_11.htm |
| EX-31.1 - EX-31.1 - ACHIEVE LIFE SCIENCES, INC. | achv-ex311_8.htm |
| EX-21.1 - EX-21.1 - ACHIEVE LIFE SCIENCES, INC. | achv-ex211_6.htm |
| EX-10.20 - EX-10.20 - ACHIEVE LIFE SCIENCES, INC. | achv-ex1020_542.htm |
| EX-10.7C - EX-10.7C - ACHIEVE LIFE SCIENCES, INC. | achv-ex107c_793.htm |
| EX-10.7B - EX-10.7B - ACHIEVE LIFE SCIENCES, INC. | achv-ex107b_794.htm |
| 10-K - 10-K - ACHIEVE LIFE SCIENCES, INC. | achv-10k_20171231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333-56704, 333-135697, 333-144552, 333-153206, 333-168820, 333-190480, 333-197937, 333-206569, and 333-221473) and Form S-3 (File Nos. 333-184829, and 333-207670) of Achieve Life Sciences, Inc. of our report dated March 1, 2018 relating to the financial statements and financial statement schedules, which appears in this Form 10-K.
|
Vancouver, Canada, |
|
/s/ PricewaterhouseCoopers LLP |
|
March 1, 2018 |
|
Chartered Professional Accountants |